Isaac Kobrin

Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension.

S. Oparil, P. Bernink, I. Kobrin, 1997, The American journal of cardiology.

Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): a new generation of calcium antagonists? Mibefradil International Study Group.

I. Kobrin, A. Schelling, G. Prager, 1996, Hypertension.

Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokinetics.

B. Martina, R. Tilvis, I. Kobrin, 1997, American heart journal.

Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.

S. Oparil, D. Abernethy, I. Kobrin, 1997, American journal of hypertension.

Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure.

E. E. van der Wall, P. Bernink, S. Braun, 1996, Clinical therapeutics.

Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.

I. Kobrin, E. Lindberg, R. Pordy, 1997, The American journal of cardiology.